On November 29, 2025, at the International Polyclinic under Cuu Long University, Duoc Cuu Long Pharmaceutical Joint Stock Company (DCL) participated in showcasing its key product groups at the Sample Pharmacy area. The event was held as part of the clinic’s official launch ceremony, attracting strong interest from the university’s leadership, medical professionals, students, and the local community.
At the exhibition booth, Duoc Cuu Long introduced its strategic product portfolios that the company is currently investing in and developing. Most notably, DCL presented its pharmaceutical portfolio with more than 150 approved products, addressing treatment needs across a wide range of common medical conditions.
In addition, DCL showcased its medical device product group, comprising over 50 different items such as syringes, infusion sets, and other essential medical instruments. This product line plays an important role in the medical device supply chain for healthcare facilities, particularly in the Mekong Delta region.
Notably, DCL also introduced Vicancap empty hard capsules at the Sample Pharmacy—one of the company’s key competitive advantages—which attracted significant attention from visitors. Currently, DCL is the only manufacturer in Vietnam capable of producing and supplying empty hard capsules in multiple sizes, meeting the formulation needs of pharmaceuticals and dietary supplements.
According to a DCL representative, participating in the event served multiple strategic objectives. First and foremost, it provided an opportunity for the company to enhance brand visibility and introduce its manufacturing capabilities to medical professionals and students of Cuu Long University. “With nearly 50 years of operation, DCL aims to further strengthen its presence and reputation in Vinh Long Province as well as across the Mekong Delta,” the representative shared.
Beyond the exhibition itself, the event also opened up opportunities for collaboration between DCL and the International Polyclinic – Cuu Long University. Accompanying the clinic’s launch is seen as a positive first step toward future cooperation in the supply of pharmaceuticals and medical devices, as well as joint initiatives in practical training for students. This aligns well with the university’s orientation of strengthening partnerships between educational institutions and enterprises in healthcare training and community care.
Following the event, DCL has set out several objectives to maximize the effectiveness of the connections established. The company expects to further enhance brand recognition within the local medical community while expanding long-term cooperation with Cuu Long University in areas such as education, research, and the development of human resources in the pharmaceutical and healthcare sectors.
In addition, DCL aims to explore product distribution opportunities through the International Polyclinic, considering it a potential channel to reach patients. Professional feedback from doctors and pharmacists at the clinic will also serve as valuable input to help the company further improve and upgrade its product portfolio in the coming period.
With a strong commitment to supporting the development of local healthcare and education, DCL affirms its continued collaboration with the university and related partners, thereby contributing to the improvement of community healthcare quality and advancing its vision of becoming the most highly regarded Vietnamese pharmaceutical company by patients, partners, and employees through innovative, accessible products and services, and the highest standards of care.
